Robert J. Terifay, EVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 69,897 shares at $468.19 ($32.7M) on 2017-06-16, disclosed to the SEC on 2017-06-19.
Open-market sale of $32.7M REGN by EVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $468.69 | 5,411 | $2.5M | 7.7% |
| 2 | $468.69 | 22,192 | $10.4M | 31.8% |
| 3 | $468.19 | 21,147 | $9.9M | 30.2% |
| 4 | $468.19 | 21,147 | $9.9M | 30.2% |
| Total | $468.39 avg | 69,897 | $32.7M | 100% |
| Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |
| REGN | SELL | 2014-02-19 | $4.3M | — | Filing → |